Steven P. Gelone - Oct 31, 2021 Form 4 Insider Report for Nabriva Therapeutics plc (NBRV)

Role
President and COO, Director
Signature
/s/ J. Christopher Naftzger, by power of attorney
Stock symbol
NBRV
Transactions as of
Oct 31, 2021
Transactions value $
-$72
Form type
4
Date filed
11/1/2021, 07:50 PM
Previous filing
Oct 8, 2021
Next filing
Nov 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRV Ordinary Shares Tax liability -$73 -63 -0.02% $1.15 366K Oct 31, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.